Recently, much attention has been given to discovering natural compounds as potent anti-
cancer candidates. In the present study, the anti-
cancer effects of
fumigaclavine C, isolated from a marine-derived fungus, Aspergillus fumigatus, was evaluated in vitro. In order to investigate the impact of
fumigaclavine C on inhibition of proliferation and induction of apoptosis in
breast cancer, MCF-7 cells were treated with various concentrations of
fumigaclavine C, and
fumigaclavine C showed significant cytotoxicity towards MCF-7 cells. Anti-proliferation was analyzed via cell mobility and
mitogen-activated protein kinase (MAPK) signaling pathway. In addition,
fumigaclavine C showed potent inhibition on the
protein and gene level expressions of MMP-2, -9 in MCF-7 cells which were manifested in Western blot and reverse transcription polymerase chain reaction (RT-PCR) results. The apoptosis induction abilities of the fumigaclvine C was studied by analyzing the expression of apoptosis related
proteins, cell cycle analysis, DNA fragmentation and molecular docking studies. It was found that
fumigaclavine C fragmented the MCF-7 cell
DNA and arrested the cell cycle by modulating the apoptotic
protein expressions. Moreover,
fumigaclavine C significantly down-regulated the
NF-kappa-B cell survival pathway. Collectively, data suggest that
fumigaclavine C has a potential to be developed as a therapeutic candidate for
breast cancer.